The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The survival outcomes for men with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination deficiencies (HRD) treated with radium-223: Princess Margaret Cancer Centre (PMCC) experience.
 
Esmail M. Al-Ezzi
No Relationships to Disclose
 
Osama Abdeljalil
No Relationships to Disclose
 
Katherine Lajkosz
No Relationships to Disclose
 
Shreya S. Gramolini
No Relationships to Disclose
 
Nely Mercy Diaz Mejia
No Relationships to Disclose
 
Husam Alqaisi
No Relationships to Disclose
 
Jenny Peng
No Relationships to Disclose
 
Richard Thomas O'Dwyer
No Relationships to Disclose
 
Mohammed Alghamdi
No Relationships to Disclose
 
Sulaiman Almuthri
No Relationships to Disclose
 
Vikaash Kumar
No Relationships to Disclose
 
Di Maria Jiang
Honoraria - Amgen; AstraZeneca; Bayer; EMD Serono; Ipsen; Janssen Oncology; Janssen Oncology; Janssen Oncology; Janssen Oncology
Consulting or Advisory Role - AstraZeneca/Merck; Bayer; Janssen Oncology; McKesson; MD Serono and Pfizer; Novartis AAA; Novartis AAA; Pfizer/EMD Serono; Pfizer/EMD Serono
Research Funding - Amgen; Astellas Pharma (Inst); Tersera
Travel, Accommodations, Expenses - EMD Serono
 
Nazanin Fallah-Rad
Honoraria - Bayer; Ipsen; Merck/Pfizer
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Nektar
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Research Funding - Bayer (Inst); Janssen (Inst); Pfizer (Inst)